Tongli Pharmaceuticals (USA) I - TGLP - Financial Statement Analysis
All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.
In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.
Financial statement analysis updated: May 19, 2013
Tongli Pharmaceuticals (USA) I - SIC # 2834
| Ticker | Exchange | SIC # | Website | Latest Ticker |
|---|---|---|---|---|
| TGLP | Over the counter | 2834 | http://www.tonglipharma.com | 0.07 0.00 |
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: |
||||
Latest Headlines for Tongli Pharmaceuticals (USA) I
TONGLI PHARMACEUTICALS (USA), INC. Financials - Feb 21st, 2013 11:04 am
TONGLI PHARMACEUTICALS (USA), INC. Files SEC form 10-Q, Quarterly Report - Feb 14th, 2013 7:55 am
TONGLI PHARMACEUTICALS (USA), INC. Files SEC form 10-Q, Quarterly Report - Nov 14th, 2012 8:48 am
TONGLI PHARMACEUTICALS (USA), INC. Files SEC form 10-Q, Quarterly Report - Aug 14th, 2012 2:55 pm
TONGLI PHARMACEUTICALS (USA), INC. Financials - Jul 25th, 2012 11:04 am
TONGLI PHARMACEUTICALS (USA), INC. Files SEC form 10-K, Annual Report - Jul 16th, 2012 12:33 pm
View All Current Headlines >> |
||||
